Loss of NDRG2 mRNA and protein levels was found in anaplastic (grade III) meningiomas and in a clinically aggressive subset of atypical (grade II) meningiomas, most likely caused by NDRG2 CpG promoter methylation [66]. This evidence concerns the gene NDRG2 and meningioma.